Structure and Ligand Based Rational Drug Design for Bace-1 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|9|1|14-20

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.9, Iss.1, 2013-03, pp. : 14-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based &bgr;-Secretase (BACE1) Inhibitors

By  

Current Pharmaceutical Design, Vol. 20, Iss. 20, 2014-05 ,pp. : 3373-3379

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay

By  

Current Computer - Aided Drug Design, Vol. 12, Iss. 1, 2016-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-Based Drug Design to Propose Novel -Glucosidase Inhibitors

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand Based Drug Design Strategies in the Development of Novel 5- LOX Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 22, 2012-08 ,pp. : 3763-3778

Bentham Science Publishers

Access to resources Recommend Favorite